Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: Need to assess aspirin resistance?
- 15 April 2004
- journal article
- case report
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 62 (1) , 39-42
- https://doi.org/10.1002/ccd.10756
Abstract
We report on a patient presenting with late thrombosis of a stent 15 months after being treated with intracoronary brachytherapy. It occurred 17 days after clopidogrel withdrawal while maintaining treatment with aspirin. At the time of stent thrombosis, evaluation of platelet aggregation was performed, revealing a suboptimal response to aspirin. Pathophysiological insights of aspirin resistance and clinical implications are reviewed. Catheter Cardiovasc Interv 2004;62:39–42.Keywords
This publication has 11 references indexed in Scilit:
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery diseaseThrombosis Research, 2002
- Twelve Versus Six Months of Clopidogrel to Reduce Major Cardiac Events in Patients Undergoing γ-Radiation Therapy for In-Stent RestenosisCirculation, 2002
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001
- Prolonged Antiplatelet Therapy to Prevent Late Thrombosis After Intracoronary γ-Radiation in Patients With In-Stent RestenosisCirculation, 2001
- Late Coronary Occlusion After Intracoronary BrachytherapyCirculation, 1999
- Late Thrombosis After RadiationCirculation, 1999
- Erythrocyte Promotion of Platelet Reactivity Decreases the Effectiveness of Aspirin as an Antithrombotic Therapeutic ModalityCirculation, 1998
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994